Evidence map›Paper›PMID 40396503›Full record

ArticleClinical trials (London, England)2025

Concordance between clinical trial data use request proposals and corresponding publications: A cross-sectional study.

Enrique Vazquez, Joseph S Ross, Cary P Gross, Karla Childers, Stephen Bamford, Jessica D Ritchie, Joanne Waldstreicher, Harlan M Krumholz, Joshua D Wallach

Abstract read
In one paragraph

Article in Clinical trials (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Enrique VazquezYale University, New Haven, CT, USA.
Joseph S RossSection of General Internal Medicine, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-9218-3320
Cary P GrossSection of General Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Karla ChildersJohnson & Johnson, New Brunswick, NJ, USA.
Stephen BamfordJohnson & Johnson, High Wycombe, UK.
Jessica D RitchieYale-New Haven Hospital Center for Outcomes Research and Evaluation, New Haven, CT, USA.
Joanne WaldstreicherJohnson & Johnson, New Brunswick, NJ, USA.ORCID 0000-0002-3992-4636
Harlan M KrumholzYale-New Haven Hospital Center for Outcomes Research and Evaluation, New Haven, CT, USA.
Joshua D WallachDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.ORCID 0000-0002-2816-6905

Funding

Identifying Patient Subgroups That Are Most Likely To Benefit From Medications Used To Treat Alcohol Use DisorderK01AA028258 · NIAAA · YALE UNIVERSITY · PI WALLACH, JOSHUA DAVID · 2021 to 2025
$892k
NIAAA NIH HHS K01 AA028258
6 · The paper itself

Abstract

Background/AimsThe reuse of clinical trial data available through data-sharing platforms has grown over the past decade. Several prominent clinical data-sharing platforms require researchers to submit formal research proposals before granting data access, providing an opportunity to evaluate how published analyses compare with initially proposed aims. We evaluated the concordance between the included trials, study objectives, endpoints, and statistical methods specified in researchers' clinical trial data use request proposals to four clinical data-sharing platforms and their corresponding publications.MethodsWe identified all unique data request proposals with at least one corresponding peer-reviewed publication as of 31 March 2023 on four prominent clinical trial data sharing request platforms (Vivli, ClinicalStudyDataRequest.com, the Yale Open Data Access Project, and Supporting Open Access to Researchers-Bristol Myers Squibb). When data requests had multiple publications, we treated each publication-request pair as a unit. For each pair, the trials requested and analyzed were classified as fully concordant, discordant, or unclear, whereas the study objectives, primary and secondary endpoints, and statistical methods were classified as fully concordant, partially concordant, discordant, or unclear. For Vivli, ClinicalStudyDataRequest.com, and Supporting Open Access to Researchers-Bristol Myers Squibb, endpoints of publication-request pairs were not compared because the data request proposals on these platforms do not consistently report this information.ResultsOf 117 Vivli publication-request pairs, 76 (65.0%) were fully concordant for the trials requested and analyzed, 61 (52.1%) for study objectives, and 57 (48.7%) for statistical methods; 35 (29.9%) pairs were fully concordant across the 3 characteristics reported by all platforms. Of 106 ClinicalStudyDataRequest.com publication-request pairs, 66 (62.3%) were fully concordant for the trials requested and analyzed, 41 (38.7%) for study objectives, and 35 (33.0%) for statistical methods; 20 (18.9%) pairs were fully concordant across the 3 characteristics. Of 65 Yale Open Data Access Project publication-request pairs, 35 (53.8%) were fully concordant for the trials requested and analyzed, 44 (67.7%) for primary study objectives, and 25 (38.5%) for statistical methods; 15 (23.1%) pairs were fully concordant across the 3 characteristics. In addition, 26 (40.0%) and 2 (3.1%) Yale Open Data Access Project publication-request pairs were concordant for primary and secondary endpoints, respectively, such that only one (1.5%) Yale Open Data Access Project publication-request pair was fully concordant across all five characteristics reported. Of three Supporting Open Access to Researchers-Bristol Myers Squibb publication-request pairs, one (33.3%) was fully concordant for the trials requested and analyzed, two (66.6%) for primary study objectives, and two (66.6%) for statistical methods; one (33.3%) pair was fully concordant across all three characteristics reported by all platforms.ConclusionAcross four clinical data sharing platforms, data request proposals were often discordant with their corresponding publications, with only 25% concordant across all three key proposal characteristics reported by each platform. Opportunities exist for investigators to describe any data-sharing request proposal deviations in their publications and for platforms to enhance the reporting of key study characteristic specifications.

Indexed as

Clinical Trials as TopicInformation DisseminationPublicationsResearch DesignCross-Sectional StudiesHumansClinical trialsdata sharingtransparency

Identifiers

PMID40396503
PMCPMC12095927

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.